Coronavirus disease (COVID-19)

Situation Report – 115

Data as received by WHO from national authorities by 10:00 CEST, 14 May 2020

Highlights

Lesotho reported its first case of COVID-19.

WHO has published an interim guidance document on Laboratory biosafety for testing of clinical
specimens of patients that meet the case definition of coronavirus disease (COVID-19).

WHO Director-General Dr. Tedros in his media briefing yesterday, highlighted the urgent need for all
countries to invest in strong health systems and primary healthcare, as the best defence against
outbreaks like COVID-19. The World Health Statistics published by WHO, show that people around the
world are living longer and healthier lives overall with the biggest gains in low-income countries.
However, the report also shows that the rate of progress is too slow to meet the Sustainable
Development Goals and will be further thrown off track by COVID-19.

WHO announced the launch of the WHO Academy and the WHO info mobile applications . The WHO
Academy app is designed to support health workers during COVID-19 while the WHO Info app will
provide the general public with real-time mobile access to the latest news and developments.

In the light of overcrowding in many places of detention, which undermines hygiene, health, safety and
human dignity, UNODC,WHO,UNAIDS and OHCHR released a joint statement on COVID-19 in prisons
and other closed settings to urgently draw the attention of political leaders to the heightened
vulnerability of prisoners and other people deprived of liberty due to COVID-19 pandemic.

Situation in numbers (by WHO Region)

Total (new cases in last 24 hours)

Globally 4 248 389 cases (77 965) 294 046 deaths (6 647)

Africa 51 752 cases (2 323) 1 567 deaths (67)

Americas 1 819 553 cases (37 989) 109 121 deaths (2 617)
Eastern Mediterranean 293 805 cases (9 535) 9 389 deaths (130)
Europe 1 801 668 cases (21 352) 163 413 deaths (3 614)
South-East Asia 116 617 cases (5 685) 3 921 deaths (175)
Western Pacific 164 282 cases (1 081) 6 622 deaths (44)
Subject in Focus: Cleaning and Disinfection of Environmental Surfaces
Like other coronaviruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped
virus with an outer lipid envelope, which makes it more susceptible to disinfectants compared to non-
enveloped viruses such as rotavirus, norovirus, and poliovirus.1 The virus that causes COVID-19 is
transmitted mainly through close contact and respiratory droplets, with possible airborne transmission
in settings where procedures that can generate aerosol are performed.2 Although fomites and
contaminated surfaces have yet to be conclusively linked to transmission of SARS-CoV-2, demonstration
of surface contamination in healthcare settings3 and experiences with surface contamination linked to
subsequent infection transmission in other coronaviruses, have informed the development of cleaning
and disinfection recommendations to mitigate the potential of fomite transmission of SARS-CoV-2 in
healthcare3 and non-healthcare settings.4
In healthcare settings, environmental surfaces include the surfaces of furniture and other fixed items (e.g.
tables, chairs, walls, light switches, computer peripherals) as well as the surfaces of non-critical medical
equipment (equipment that only comes into contact with intact skin, such as blood pressure cuffs,
wheelchairs, incubators).6 These surfaces should be frequently cleaned with water and detergent and
followed by application of a disinfectant. Among the most common disinfectants used which have been
demonstrated to be effective against SARS-CoV-2 are: ethanol 70-90%; chlorine-based products (e.g.,
hypochlorite) at 0.1% (1000 ppm) for general environmental disinfection or 0.5% (5000 ppm) for blood
and body fluids large spills; or hydrogen peroxide >0.5%.5- 6 The minimal time recommended of exposition
to the surface for these disinfectants is one minute1 or according to the manufacturer instructions.
In non-healthcare settings, environmental surfaces include furniture and other fixed items, such as
counter tops, stairway rails, as well as floors and walls. Disinfectants should be applied to high touch
surfaces to reduce potential SARS-CoV-2 virus contamination in community settings where the risk of
contamination is unknown (e.g. gyms, offices, restaurants, accommodation sector) as well as in
households and non-traditional facilities where individuals with suspected or confirmed COVID-19
disease are accommodated.
In indoor spaces, routine application of disinfectants to environmental surfaces via spraying or fogging
(also known as fumigation or misting) is not recommended. Spraying environmental surfaces in both
health care and non-healthcare settings (e.g. patient households) with disinfectants will not be effective
and may pose harm to individuals.7-10 If disinfectants are to be applied, manual surface cleaning with
detergent and water using applied friction (e.g. brushing, scrubbing) must be performed first to ensure
physical removal of organic materials, followed by use of a cloth or wipe which is soaked in the
disinfectant.
Spraying or fumigation of outdoor spaces (such as streets, sidewalks, walkways or marketplaces), is not
recommended to remove or inactivate SARS-CoV-2 or other pathogens. Streets and sidewalks are not
considered as routes of infection for COVID-19. Moreover, disinfectants are inactivated by dirt and debris,
and it is not feasible to manually clean and remove all organic matter from such spaces. Even in the
absence of organic matter, chemical spraying is unlikely to adequately cover all surfaces for the duration
of the required contact time to inactivate pathogens.
Spraying individuals with disinfectants (such as in a tunnel, cabinet, or chamber) is not recommended
under any circumstances. This practice could be physically and psychologically harmful and would not
reduce an infected person’s ability to spread the virus through droplets or contact. The toxic effect of
spraying with chemicals such as chlorine on individuals can lead to eye and skin irritation, bronchospasm
due to inhalation, and potentially gastrointestinal effects such as nausea and vomiting.9, 11
The role of fomites as a mode of transmission of COVID-19 in general, and the necessity of disinfection
practices to mitigate transmission of the virus outside of healthcare environments is currently unknown.
However, infection prevention and control principles designed to mitigate the spread of pathogens in
health settings, including cleaning and disinfection practices, have been widely adapted in current
guidance to be applied in non-healthcare setting environments.12-21 In all settings, including settings
where resource limitations may not permit cleaning and disinfection to be performed regularly, frequent
hand washing and avoiding touching of the face should be considered the primary prevention approach
to mitigate the suspected mode of transmission associated with surface contamination.22

References
1. Rutala, W.A., Weber, D.J., 2019. Best practices for disinfection of noncritical environmental surfaces and
equipment in health care facilities: A bundle approach. Am J Infect Control 47, A96–A105.
(https://doi.org/10.1016/j.ajic.2019.01.014, accessed 6 May 2020)
2. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. Geneva: World
Health Organization; (https://www.who.int/publications-detail/modes-of-transmission-of-virus-causing-covid-19-
implications-for-ipc-precaution-recommendations, accessed 6 May 2020)
3. Cheng, V.C.C., Wong, S.-C., Chen, J.H.K., Yip, C.C.Y., Chuang, V.W.M., Tsang, O.T.Y., et al, 2020. Escalating infection
control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-
2 in Hong Kong. Infect. Control Hosp. Epidemiol. 41, 493–498. (https://doi.org/10.1017/ice.2020.58, accessed 6 May
2020)
4. Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., Hsueh, P.-R., 2020. Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents
55, 105924. (https://doi.org/10.1016/j.ijantimicag.2020.105924, accessed 6 May 2020)
5. Ramesh, N., Siddaiah, A., Joseph, B., 2020. Tackling corona virus disease 2019 (COVID 19) in workplaces. Indian J
Occup Environ Med 24, 16. (https://doi.org/10.4103/ijoem.IJOEM_49_20, accessed 6 May 2020)
6. R Bennett, J.E., Dolin, R., Blaser, M.J. (Eds.), 2015. Mandell, Douglas, and Bennett’s principles and practice of
infectious diseases, Eighth edition. ed. Elsevier/Saunders, Philadelphia, PA.
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099662/#!po=52.8226, accessed 14 May 2020)
7. Roth, K., Michels, W., 2005. Inter-hospital trials to determine minimal cleaning performance according to the
guideline by DGKH, DGSV and AKI 13, 106-110+112.
(https://www.researchgate.net/profile/Winfried_Michels/publication/292641729_Inter-
hospital_trials_to_determine_minimal_cleaning_performance_according_to_the_guideline_by_DGKH_DGSV_and
_AKI/links/571a4d4108ae7f552a472e88/Inter-hospital-trials-to-determine-minimal-cleaning-performance-
according-to-the-guideline-by-DGKH-DGSV-and-AKI.pdf, accessed 6 May 2020)
8. Zock, J.-P., Plana, E., Jarvis, D., Antó, J.M., Kromhout, H., Kennedy, S.M., Künzli, N., et al., 2007. The Use of Household
Cleaning Sprays and Adult Asthma: An International Longitudinal Study. Am J Respir Crit Care Med 176, 735–741.
(https://doi.org/10.1164/rccm.200612-1793OC, accessed 6 May 2020)
9. Mehtar, S., Bulabula, A.N.H., Nyandemoh, H., Jambawai, S., 2016. Deliberate exposure of humans to chlorine-the
aftermath of Ebola in West Africa. Antimicrob Resist Infect Control 5, 45. (https://doi.org/10.1186/s13756-016-0144-
1, accessed 6 May 2020)
10. Schyllert, C., Rönmark, E., Andersson, M., Hedlund, U., Lundbäck, B., Hedman, L., et al., 2016. Occupational exposure
to chemicals drives the increased risk of asthma and rhinitis observed for exposure to vapours, gas, dust and fumes:
a cross-sectional population-based study. Occup Environ Med 73, 663–669. (https://doi.org/10.1136/oemed-2016-
103595, accessed 6 May 2020)
11. Benzoni, T., Hatcher, J.D., 2020. Bleach Toxicity, in: StatPearls. StatPearls Publishing, Treasure Island (FL).
(https://www.ncbi.nlm.nih.gov/books/NBK441921/, accessed 6 May 2020)
12. Practical considerations and recommendations for Religious Leaders and Faith-based Communities in the context of
COVID-19. Geneva: World Health Organization; 2020 (https://www.who.int/publications-detail/practical-
considerations-and-recommendations-for-religious-leaders-and-faith-based-communities-in-the-context-of-covid-
19, accessed 10 May 2020)
13. Infection prevention and control for the safe management of a dead body in the context of COVID-19: interim
guidance. Geneva: World Health Organization; 2020 (https://www.who.int/publications-detail/infection-
prevention-and-control-for-the-safe-management-of-a-dead-body-in-the-context-of-covid-19-interim-guidance,
accessed 10 May 2020)
14. Getting your workplace ready for COVID-19: How COVID-19 spreads. Geneva; World Health Organization; 2020
(https://www.who.int/who-documents-detail/getting-your-workplace-ready-for-covid-19-how-covid-19-spreads)
15. COVID-19 and food safety: Guidance for food businesses. Geneva; World Health Organization; 2020
(https://apps.who.int/iris/bitstream/handle/10665/331705/WHO-2019-nCoV-Food_Safety-2020.1-eng.pdf,
accessed 10 May 2020)
16. Operational considerations for COVID-19 management in the accommodation sector. Geneva; World Health
Organization; 2020 (https://apps.who.int/iris/bitstream/handle/10665/331937/WHO-2019-nCoV-Hotels-2020.2-
eng.pdf, accessed 10 May 2020)
17. Operational considerations for managing COVID-19 cases or outbreak in aviation: interim guidance. Geneva; World
Health Organization; 2020 (https://www.who.int/publications-detail/operational-considerations-for-managing-
covid-19-cases-or-outbreak-in-aviation-interim-guidance, accessed 10 May 2020)
18. Operational considerations for managing COVID-19 cases or outbreaks on board ships: interim guidance. Geneva;
World Health Organization; 2020 (https://www.who.int/publications-detail/operational-considerations-for-
managing-covid-19-cases-or-outbreaks-on-board-ships-interim-guidance, accessed 10 May 2020)
19. Key Messages and Actions for COVID-19 Prevention and Control in Schools. Geneva; World Health Organization;
2020 (https://www.who.int/docs/default-source/coronaviruse/key-messages-and-actions-for-covid-19-
prevention-and-control-in-schools-march-2020.pdf?sfvrsn=baf81d52_4, accessed 10 May 2020)
20. Preparedness, prevention and control of COVID-19 in prisons and other places of detention. Geneva: World Health
Organization; 2020 (http://www.euro.who.int/en/health-topics/health-determinants/prisons-and-
health/publications/2020/preparedness,-prevention-and-control-of-covid-19-in-prisons-and-other-places-of-
detention-2020, accessed 10 May 2020)
21. Water, sanitation, hygiene, and waste management for the COVID-19 virus. Geneva: World Health Organization;
(https://apps.who.int/iris/bitstream/handle/10665/331846/WHO-2019-nCoV-IPC_WASH-2020.3-eng.pdf,
accessed 6 May 2020)
22. Coronavirus disease (COVID-19) advice for the public. Geneva: World Health Organization;
(https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public, accessed 14 May 2020)
Surveillance
Figure 1. Number of confirmed COVID-19 cases reported in the last seven days by country, territory or area, 8 May to 14 May**

**See Annex 1 for data, table and figure notes.

Figure 2. Number of confirmed COVID-19 cases, by date of report and WHO region, 30 December 2019 through 14 May 2020**

**See Annex 1 for data, table and figure notes.

Table 1. Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths, by WHO region. Data as of 10 AM CEST, 14 May 2020**
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Africa
South Africa 12 074 724 219 13 Community transmission 0
Algeria 6 253 186 522 7 Community transmission 0
Ghana 5 408 281 24 2 Community transmission 0
Nigeria 4 971 184 164 6 Community transmission 0
Cameroon 2 800 111 136 11 Community transmission 0
Guinea 2 372 74 14 3 Community transmission 0
Senegal 2 105 110 22 3 Community transmission 0
Côte d’Ivoire 1 912 55 24 3 Community transmission 0
Democratic Republic of the Congo 1 242 73 50 0 Community transmission 0
Gabon 1 004 141 9 0 Community transmission 0
Niger 860 6 49 2 Community transmission 0
Guinea-Bissau 836 16 3 0 Community transmission 0
Burkina Faso 773 7 51 0 Community transmission 0
Mali 758 28 44 4 Community transmission 0
Kenya 737 22 40 4 Community transmission 0
Equatorial Guinea 583 61 7 1 Community transmission 0
United Republic of Tanzania 509 0 21 0 Community transmission 6
Zambia 446 5 7 0 Community transmission 0
Sierra Leone 387 49 21 1 Clusters of cases 0
Chad 372 15 42 2 Community transmission 0
Congo 341 8 11 0 Community transmission 0
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Mauritius 332 0 10 0 Clusters of cases 17
Benin 327 0 2 0 Community transmission 1
Cabo Verde 289 19 2 0 Clusters of cases 0
Rwanda 287 1 0 0 Sporadic cases 0
Ethiopia 263 2 5 0 Clusters of cases 0
Togo 219 20 11 0 Community transmission 0
Liberia 213 1 20 0 Community transmission 0
Madagascar 212 20 0 0 Clusters of cases 0
South Sudan 194 20 0 0 Clusters of cases 0
Central African Republic 187 8 0 0 Sporadic cases 0
Eswatini 187 3 2 0 Clusters of cases 0
São Tomé and Príncipe 165 0 7 3 Clusters of cases 4
Uganda 139 13 0 0 Sporadic cases 0
Mozambique 107 3 0 0 Clusters of cases 0
Malawi 63 5 3 0 Clusters of cases 0
Angola 45 0 2 0 Clusters of cases 3
Eritrea 39 0 0 0 Sporadic cases 25
Zimbabwe 37 0 4 0 Sporadic cases 1
Burundi 27 0 1 0 Clusters of cases 1
Botswana 24 0 1 0 Clusters of cases 2
Gambia 23 0 1 0 Sporadic cases 1
Namibia 16 0 0 0 Sporadic cases 38
Comoros 11 0 1 0 Community transmission 4
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Seychelles 11 0 0 0 Clusters of cases 37
Mauritania 9 1 1 0 Sporadic cases 0
Lesotho 1 1 0 0 Pending 0
ii
Territories
Mayotte 1 143 48 14 2 Clusters of cases 0
Réunion 439 2 0 0 Clusters of cases 0
Americas
United States of America 1 340 098 18 044 80 695 1 061 Community transmission 0
Brazil 177 589 9 258 12 400 881 Community transmission 0
Peru 72 059 3 237 2 057 96 Community transmission 0
Canada 71 486 1 144 5 209 160 Community transmission 0
Mexico 38 324 1 997 3 926 353 Community transmission 0
Chile 34 381 2 660 346 11 Community transmission 0
Ecuador 30 486 67 2 334 7 Community transmission 0
Colombia 12 272 659 493 14 Community transmission 0
Dominican Republic 11 196 296 409 7 Community transmission 0
Panama 8 616 0 249 0 Community transmission 1
Argentina 6 563 285 321 4 Community transmission 0
Bolivia (Plurinational State of) 2 964 133 128 6 Clusters of cases 0
Honduras 2 080 - 20 121 5 Community transmission 0
Cuba 1 810 6 79 1 Clusters of cases 0
Guatemala 1 199 85 27 1 Clusters of cases 0
El Salvador 1 037 39 20 2 Clusters of cases 0
Costa Rica 804 3 7 0 Clusters of cases 0
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Paraguay 740 3 11 1 Community transmission 0
Uruguay 717 6 19 0 Clusters of cases 0
Jamaica 507 2 9 0 Clusters of cases 0
Venezuela (Bolivarian Republic of) 440 18 10 0 Clusters of cases 0
Haiti 219 10 18 2 Clusters of cases 0
Trinidad and Tobago 116 0 8 0 Sporadic cases 16
Guyana 113 4 10 0 Clusters of cases 0
Bahamas 93 0 11 0 Clusters of cases 1
Barbados 85 1 7 0 Clusters of cases 0
Antigua and Barbuda 25 0 3 0 Clusters of cases 10
Nicaragua 25 9 8 3 Pending 0
Grenada 21 0 0 0 Clusters of cases 10
Belize 18 0 2 0 Sporadic cases 29
Saint Lucia 18 0 0 0 Sporadic cases 9
Saint Vincent and the Grenadines 17 0 0 0 Sporadic cases 9
Dominica 16 0 0 0 Clusters of cases 33
Saint Kitts and Nevis 15 0 0 0 Sporadic cases 23
Suriname 10 0 1 0 Sporadic cases 40
Territoriesii
Puerto Rico 2 329 30 115 1 Clusters of cases 0
Martinique 189 2 14 0 Clusters of cases 0
Guadeloupe 155 0 13 0 Clusters of cases 1
French Guiana 153 7 1 0 Clusters of cases 0
Bermuda 121 2 8 0 Clusters of cases 0
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Aruba 101 0 3 0 Sporadic cases 8
Cayman Islands 85 1 1 0 Clusters of cases 0
Sint Maarten 78 1 15 0 Sporadic cases 0
United States Virgin Islands 69 0 6 1 Clusters of cases 3
Saint Martin 39 0 3 0 Sporadic cases 3
Curaçao 16 0 1 0 Sporadic cases 16
Falkland Islands (Malvinas) 13 0 0 0 Clusters of cases 18
Turks and Caicos Islands 12 0 1 0 Sporadic cases 16
Montserrat 11 0 1 0 Sporadic cases 30
British Virgin Islands 7 0 1 0 Sporadic cases 8
Bonaire, Sint Eustatius and Saba 6 0 0 0 Sporadic cases 16
Saint Barthélemy 6 0 0 0 Sporadic cases 44
Anguilla 3 0 0 0 Sporadic cases 40
Saint Pierre and Miquelon 1 0 0 0 Sporadic cases 36
Eastern Mediterranean
Iran (Islamic Republic of) 112 725 1 958 6 783 50 Community transmission 0
Saudi Arabia 44 830 1 905 273 9 Clusters of cases 0
Pakistan 35 298 1 037 761 24 Clusters of cases 0
Qatar 26 539 1 390 14 0 Community transmission 0
United Arab Emirates 20 386 725 206 3 Pending 0
Kuwait 11 028 751 82 7 Clusters of cases 0
Egypt 10 431 338 556 12 Clusters of cases 0
Morocco 6 512 94 188 0 Clusters of cases 0
Bahrain 5 816 285 10 1 Clusters of cases 0
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Afghanistan 5 339 372 136 9 Clusters of cases 0
Oman 4 341 322 17 0 Clusters of cases 0
Iraq 3 032 119 115 3 Clusters of cases 0
Sudan 1 817 157 90 10 Sporadic cases 0
Djibouti 1 268 12 3 0 Clusters of cases 0
Somalia 1 219 49 52 0 Sporadic cases 0
Tunisia 1 032 0 45 0 Community transmission 4
Lebanon 878 8 26 0 Clusters of cases 0
Jordan 582 6 9 0 Clusters of cases 0
Yemen 72 5 13 2 Pending 0
Libya 64 0 3 0 Clusters of cases 7
Syrian Arab Republic 48 1 3 0 Community transmission 0
Territoriesii
occupied Palestinian territory 548 1 4 0 Clusters of cases 0
Europe
Russian Federation 252 245 9 974 2 305 93 Clusters of cases 0
The United Kingdom 229 709 3 242 33 186 494 Community transmission 0
Spain 228 691 661 27 104 184 Community transmission 0
Italy 222 104 888 33 106 2 195 Community transmission 0
Germany 172 239 933 7 723 89 Community transmission 0
Turkey 143 114 1 639 3 952 58 Community transmission 0
France 138 609 448 27 029 81 Community transmission 0
Belgium 53 981 202 8 843 82 Community transmission 0
Netherlands 43 211 227 5 562 52 Community transmission 0
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Switzerland 30 330 33 1 563 3 Community transmission 0
Portugal 28 132 219 1 175 12 Community transmission 0
Sweden 27 909 637 3 460 147 Community transmission 0
Belarus 25 840 0 149 0 Clusters of cases 1
Ireland 23 401 159 1 497 9 Community transmission 0
Poland 17 204 283 861 22 Community transmission 0
Ukraine 16 847 422 456 17 Community transmission 0
Israel 16 539 0 262 0 Pending 1
Romania 16 002 224 1 016 14 Community transmission 0
Austria 15 964 54 624 1 Community transmission 0
Denmark 10 667 76 533 6 Community transmission 0
Serbia 10 295 52 222 2 Pending 0
Czechia 8 269 48 290 7 Community transmission 0
Norway 8 158 23 229 1 Pending 0
Finland 6 054 51 284 9 Pending 0
Kazakhstan 5 571 154 33 1 Pending 0
Republic of Moldova 5 406 252 190 8 Pending 0
Luxembourg 3 904 10 103 1 Pending 0
Armenia 3 836 118 49 1 Clusters of cases 0
Hungary 3 380 39 436 6 Clusters of cases 0
Greece 2 760 16 155 3 Community transmission 0
Azerbaijan 2 758 65 35 2 Clusters of cases 0
Uzbekistan 2 620 22 11 1 Clusters of cases 0
Croatia 2 213 6 94 3 Community transmission 0
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Bosnia and Herzegovina 2 181 19 119 3 Community transmission 0
Bulgaria 2 069 46 96 1 Clusters of cases 0
Iceland 1 802 1 10 0 Community transmission 0
Estonia 1 751 5 61 0 Pending 0
North Macedonia 1 694 20 95 3 Clusters of cases 0
Lithuania 1 505 14 54 4 Community transmission 0
Slovakia 1 469 4 27 0 Clusters of cases 0
Slovenia 1 463 2 103 1 Community transmission 0
Kyrgyzstan 1 082 38 12 0 Clusters of cases 0
Latvia 951 1 19 1 Community transmission 0
Cyprus 905 2 17 -6 Clusters of cases 0
Albania 880 4 31 0 Clusters of cases 0
Andorra 761 2 49 1 Community transmission 0
Tajikistan 729 0 23 0 Pending 1
Georgia 652 10 11 0 Community transmission 0
San Marino 647 0 41 0 Community transmission 2
Malta 508 5 6 1 Pending 0
Montenegro 324 0 9 0 Clusters of cases 8
Monaco 96 0 1 0 Sporadic cases 3
Liechtenstein 83 0 1 0 Pending 18
Holy See 12 0 0 0 Sporadic cases 7
Territoriesii
Kosovo[1] 919 0 29 0 Community transmission 1
Isle of Man 331 1 23 0 Pending 0
Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
Jersey 295 1 26 1 Pending 0
Guernsey 252 0 13 0 Community transmission 11
Faroe Islands 187 0 0 0 Pending 20
Gibraltar 147 0 0 0 Clusters of cases 1
Greenland 11 0 0 0 Pending 38
South-East Asia
India 78 003 3 722 2 549 134 Clusters of cases 0
Bangladesh 17 822 1 162 269 19 Clusters of cases 0
Indonesia 15 438 689 1 028 21 Community transmission 0
Thailand 3 018 1 56 0 Clusters of cases 0
Maldives 955 51 4 1 Clusters of cases 0
Sri Lanka 915 26 9 0 Clusters of cases 0
Nepal 246 29 0 0 Sporadic cases 0
Myanmar 181 1 6 0 Clusters of cases 0
Timor-Leste 24 0 0 0 Clusters of cases 20
Bhutan 15 4 0 0 Sporadic cases 0
Western Pacific
China 84 464 6 4 644 0 Clusters of cases 0
Singapore 25 346 675 21 0 Clusters of cases 0
Japan 16 079 55 687 19 Clusters of cases 0
Philippines 11 618 268 772 21 Community transmission 0
Republic of Korea 10 991 29 260 1 Clusters of cases 0
Australia 6 975 11 98 1 Clusters of cases 0
Malaysia 6 779 37 111 2 Clusters of cases 0
 Reporting Country/ Territory/Area Total confirmed Total confirmed Total deaths Total new deaths Transmission Days since last
cases new cases classificationi reported case
New Zealand 1 147 0 21 0 Clusters of cases 3
Viet Nam 288 0 0 0 Clusters of cases 6
Brunei Darussalam 141 0 1 0 Clusters of cases 6
Cambodia 122 0 0 0 Sporadic cases 32
Mongolia 42 0 0 0 Sporadic cases 5
Lao People's Democratic Republic 19 0 0 0 Sporadic cases 31
Fiji 18 0 0 0 Sporadic cases 23
Papua New Guinea 8 0 0 0 Sporadic cases 21
Territoriesii
Guam 148 0 5 0 Clusters of cases 1
French Polynesia 60 0 0 0 Sporadic cases 8
Northern Mariana Islands
(Commonwealth of the) 19 0 2 0 Pending 2
New Caledonia 18 0 0 0 Sporadic cases 41
Subtotal for all regions 4 247 677 77 965 294 033 6 647
Other* 712 0 13 0 - 59
Grand total 4 248 389 77 965 294 046 6 647

**See Annex 1 for data, table and figure notes.

Technical guidance and other resources
– To view all technical guidance documents regarding COVID-19, please go to this webpage.
– Updates from WHO regional offices
– WHO AFRO – WHO PAHO
– WHO EMRO – WHO SEARO
– WHO EURO – WHO WPRO

– Research and Development

– Online courses on COVID-19 and in additional national languages
– The Strategic Preparedness and Response Plan (SPRP) outlining the support the international
community can provide to all countries to prepare and respond to the virus.
– WHO Health Emergency dashboard
– Weekly COVID-19 Operations Updates

Recommendations and advice for the public

– Protect yourself
– Questions and answers
– Travel advice
– EPI-WIN: tailored information for individuals, organizations and communities

Case definitions
WHO periodically updates the Global Surveillance for human infection with coronavirus disease
(COVID-19) document which includes surveillance definitions.

Definition of COVID-19 death

COVID-19 death is defined for surveillance purposes as a death resulting from a clinically
compatible illness in a probable or confirmed COVID-19 case, unless there is a clear alternative
cause of death that cannot be related to COVID-19 disease (e.g. trauma). There should be no period
of complete recovery between the illness and death.
Further guidance for certification and classification (coding) of COVID-19 as cause of death is
available here.
Annex 1: Data, table and figure notes
Caution must be taken when interpreting all data presented. Differences are to be expected
between information products published by WHO, national public health authorities, and other
sources using different inclusion criteria and different data cut-off times. While steps are taken to
ensure accuracy and reliability, all data are subject to continuous verification and change. Case
detection, definitions, testing strategies, reporting practice, and lag times differ between
countries/territories/areas. These factors, amongst others, influence the counts presented with
variable underestimation of true case and death counts, and variable delays to reflecting these data
at global level.
The designations employed, and the presentation of these materials do not imply the expression of
any opinion whatsoever on the part of WHO concerning the legal status of any country, territory or
area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and
dashed lines on maps represent approximate border lines for which there may not yet be full
agreement. Countries, territories and areas are arranged under the administering WHO region.
[1] All references to Kosovo should be understood to be in the context of the United Nations Security

Council resolution 1244 (1999). In the map, number of cases of Serbia and Kosovo (UNSCR 1244,
1999) have been aggregated for visualization purposes.

Counts reflect laboratory-confirmed cases and deaths, based on WHO case definitions unless stated
otherwise (see Country, territory, or area-specific updates and errata), and include both domestic
and repatriated cases.
Other*: includes cases reported under the international conveyance (Diamond Princess).
Due to the recent trend of countries conducting data reconciliation exercises which remove large
numbers of cases or deaths from their total counts, WHO will now display such data as negative
numbers in the “new cases” / “new deaths” columns as appropriate. This will aid readers in
identifying when such adjustments occur. When additional details become available that allow the
subtractions to be suitably apportioned to previous days, graphics will be updated accordingly. Prior
situation reports will not be edited; see covid19.who.int for the most up-to-date data.
Additional table notes
i Transmission classification is based on a process of country/territory/area self-reporting.
Classifications are reviewed on a weekly basis, may be revised as new information becomes
available, and are based on the highest category reported. Differing degrees of transmission may be
present within countries/territories/areas. Categories:
• No cases: with no confirmed cases (not shown in table).
• Sporadic cases: with one or more cases, imported or locally detected.
• Clusters of cases: experiencing cases, clustered in time, geographic location and/or by common
exposures.
• Community transmission: experiencing larger outbreaks of local transmission defined through
an assessment of factors including, but not limited to: large numbers of cases not linkable to
transmission chains; large numbers of cases from sentinel lab surveillance; and/or multiple
unrelated clusters in several areas of the country/territory/area.
• Pending: transmission classification not been reported to WHO.
ii “Territories” include territories, areas, overseas dependencies and other jurisdictions of similar
status.
Country, territory, or area-specific updates and errata
No major updates.